1. Infection

Infection

Infection is a pathophysiological process that involves the invasion and colonization of a living organism (host) by disease-causing infectious agents, the reaction of host tissues to these agents and the toxins they produce, and the transmission of infectious agents to other hosts. Common infectious agents include viruses, viroids, prions, bacteria, nematodes, arthropods, and other macroparasites such as tapeworms. Hosts can fight infections using their immune system. Mammals often engage both innate and adaptive immune systems to eliminate infectious agents or inhibit their growth and transmission. When infection occurs, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic), antiviral, antifungal and antiparasitic agents.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-123096
    Silthiofam 175217-20-6 98%
    Silthiofam (Silthiopham) is a wheat fungicide used to control take-all disease caused by the soil-borne fungus Gaeumannomyces graminis.
    Silthiofam
  • HY-123137
    Ro 24-6778 130838-10-7 98%
    Ro 24-6778 is a cephalosporin composed of Desacetylcefotaxime (HY-126129) and Desmethylfleroxacin ester-linked. Ro 24-6778 has high antibacterial activity against a wide range of aerobic bacteria.
    Ro 24-6778
  • HY-123156
    SC-23110 60149-28-2 98%
    SC-23110 is a potent anti-acne agent. SC-23110 inhibits the growth of P. acnes, one of the organisms associated with acne, and most frequently mentioned as the organism involved in the pathogenesis of inflammatory pustules/lesions.
    SC-23110
  • HY-123190
    Safracin A 87578-98-1 98%
    Safracin A has anti-Gram-positive bacteria, Gram-negative bacteria and anti-tumor effect.
    Safracin A
  • HY-123192
    Uredofos 52406-01-6 98%
    Uredofos is a broad-spectrum anthelmintic. Uredofos has anticestodal activity.
    Uredofos
  • HY-123216
    Cefmatilen 140128-74-1 98%
    Cefmatilen (S-1090) is an orally-active cephalosporin antibiotic that shows high activity against a variety of Gram-positive and Gram-negative bacteria, including Streptococcus pyogenes and Neisseria gonorrhoeae.
    Cefmatilen
  • HY-123219
    Salifluor 78417-90-0 98%
    Salifluor is a broad spectrum antimicrobial agent that has been investigated for its abilities to inhibit dental plaque formation. Salifluor can act as an effective anti-inflammatory agent.
    Salifluor
  • HY-123251
    DB-766 423165-22-4 98%
    DB-766 is an anti-parasite and antileishmanial agent, and is active against T. cruzi. DB-766 effectively reduces the parasite load in the blood and cardiac tissue.
    DB-766
  • HY-123265
    Luteoreticulin 22388-89-2 98%
    Luteoreticulin is a nitro-containing bacterial metabolite originally isolated from S. luteoreticuli. It has mosquitocidal activity against A. aegypti when used at a concentration of 6.25 mg/L and nematocidal activity against C. elegans.
    Luteoreticulin
  • HY-123270
    RP23618 207991-30-8 98%
    RP23618 is a non peptidic RANTES antagonist with the IC50 of 3 μM. RP23618 inhibit RANTES-induced chemotaxis of THP-1 cells.
    RP23618
  • HY-123314
    Floxacrine 53966-34-0 98%
    Floxacrine (HOE-991) is a dihydroacridinedione derivative with antimalarial activity. Floxacrine can be used to study its activity against different Plasmodium species.
    Floxacrine
  • HY-123321
    Sakyomicin A 86413-75-4 98%
    Sakyomicin A is an antibiotic isolated from Actinomycete strain M-53. Sakyomicin A is active against Gram-positive bacteria.
    Sakyomicin A
  • HY-123325
    Kapurimycin A1 132412-65-8 98%
    Kapurimycin A1 is an anbitiotic that can be isolated from Streptomyces. Kapurimycin A1 has a significant inhibitory effect on Gram-positive bacteria, exhibits cytotoxicity to cultured mammalian cells, and shows strong antitumor activity against the mouse leukemia P388 cell line.
    Kapurimycin A1
  • HY-123330
    GW695634 457635-65-3 98%
    GW695634 is an orally active prodrug of GW678248. GW695634 undergoes amidolysis in vivo to release the active ingredient GW678248, thereby inhibiting viral replication. GW678248 is a non-nucleoside reverse transcriptase inhibitor (NNRTi) with potent antiviral activity against Efavirenz (HY-10572)-resistant and Nevirapine (HY-10570)-resistant HIV and AIDS viruses.
    GW695634
  • HY-123331
    S 82-5455 90832-34-1 98%
    S 82-5455 is a floxacrine derivative that exhibits high activity against drug-susceptible strains of Plasmodium berghei induced in mouse and rat blood.
    S 82-5455
  • HY-123339
    Sannamycin G 73522-72-2 98%
    Sannamycin G (Istamycin X0) is an aminoglycoside antibiotic and has only weak antibacterial activity against a few bacteria.
    Sannamycin G
  • HY-123350
    Saroaspidin B 112663-68-0 98%
    Saroaspidin B, a dimer of a phloroglucinol moiety, is an antibiotic compound.
    Saroaspidin B
  • HY-123354
    SC 44914 115812-74-3 98%
    SC 44914 is a quinoxaline compound with antibacterial effects. SC-44914 has activity against Campylobacter jejuni, C. coli, and Clostridium difficile.
    SC 44914
  • HY-123387
    Suksdorfin 53023-17-9 98%
    Suksdorfin is a compound isolated from the fruits of Lomatium suksdorfii. Suksdorfin has activity againstHIV-1.
    Suksdorfin
  • HY-123436
    Sarubicin B 84745-01-7 98%
    Sarubicin B is an active product that can be isolated from the culture filtrate of a Streptomyces strain JA 2861. Sarubicin B is a quinone antibiotic that inhibit Gram-positive bacteria and not active against Gram-negative microorganisms.
    Sarubicin B
Cat. No. Product Name / Synonyms Application Reactivity